TT,It is a phase 1 / 2 trial, specifically targeting ASD /...

First 24 Last

Share
Profile

Follow
ink

1,413 Posts.

161

30/06/21

20:43

Post #: 54189305
Share

Originally posted by TerribleTadpole: ↑

Most companies go into phase 1 trials with a target condition in view. Neurotech don't have one yet; just a collection of loosely related neurological conditions.

So while you can do phase 1 without a target – to gather general safety, tolerance and pharmacokinetic data – they will need to come up with one in order to kick off phase 2. There is also the issue of deciding how the dose should be administered in phase 1 and hoping that the chosen method is appropriate for the target condition when one is eventually chosen. We've been given precious little information on this trial. Are the doses being inhaled as a vapour, swallowed in a capsule, injected (subcutaneous, intramuscular, intravenous, epidural), absorbed through the mouth, eaten with food, inhaled as a powder?

This is why most companies will wait until they understand what their drug is for before they embark on trials.

I'm not saying the drug is ineffective, or that the company won't make a go of it. But the way this company is going about things sniffs of cart-before-horseness.

Completion of phase 1 will not reduce risk as much as if a clear target were in view.

Expand

TT,
It is a phase 1 / 2 trial, specifically targeting ASD / autism based on a number of Israeli studies that show the effectiveness of full spectrum cannabinoids (less than 0.3 % thc ) - the dolce strains should be more effective given higher levels of cbda , cbg, cbn , cbdb and p, - do you honestly think monash health with head of paediatric neurology would run a phase 1 and 2 trial without all dosage parameters in place -

From the NTI 5th May announcement:

"Commenting on the Study, A/Profressor Michael Fahey said:

It is exciting to undertake a properly planned and executed study on a novel CBD product.Many other studies do not have the rigor to ensure that the results are translatable to evidence based clinical treatments"

Your post is deliberately false and misleading, -- is it because of your apparent love /hate relationship with BL.

NTI Price at posting: 5.3¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply